-The Telegraph New Delhi: The sale of drug combinations containing last-resort antibiotics is rising faster than overall antibiotics sales in India, health researchers have said in a study that also highlights the government's failure to stop the sale of irrational and unapproved antibiotic cocktails. While total antibiotics sales in India rose 26 per cent over a four-year period, says the study, there was a 174 per cent increase in the sales of...

-Livemint.com Govt plans to?help firms revamp manufacturing units,?refurbish machinery,?ensure subsidized power in bid to produce drugs such as penicillin at competitive rates New Delhi: The Department of Pharmaceuticals (DoP), during a meeting on Wednesday, urged pharma companies to strive for self-sufficiency in critical drugs like penicillin, rifampicin and insulin, in a sign of government concern over India’s dependence on Chinese imports. A large number of so-called active pharmaceutical ingredients (APIs), or bulk drugs,...

-The Times of India NEW DELHI: Telecom operators are bombarding their consumers with messages to link their SIM cards with Aadhaar, going so far as to threaten a disconnection in services. Those who use Airtel, Vodafone and Idea Cellular, among others, have been fielding frequent SMS alerts and tele-calls from mobile operators and their field associates, asking them to link their numbers with Aadhaar. Telecom companies cite a directive from the Department...

-The Times of India Many members of the Niti Aayog's newly constituted Working Group on Nutrition have significant conflicts of interests. Several are representatives of international agencies, which have close ties to multinational food companies including Nestle, Hindustan Unilever, Coca Cola, Monsanto, Mars and Ajinomoto, and which have been pushing packaged therapeutic food to address malnutrition. The government has repeatedly clarified that packaged energy dense food is against India's policy on...

-The Times of India NEW DELHI: In a move to ensure efficacy of medicines sold in India, the drug regulator has made it mandatory for companies to include Indian patients in global clinical trials if they want to market in India a new drug developed outside the country. The decision was taken in a recent technical committee meeting, headed by director general of health services Jagdish Prasad. The committee, which was formed...